IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Financial Statements — LFMDP

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021
Cash & Equivalents25.1434.48--36.2334.3937.5935.7035.1115.2911.9111.525.8411.7225.089.4517.4113.41
Accounts Receivable11.269.869.247.3310.196.055.675.344.423.672.942.542.511.801.501.611.35
Inventory2.963.183.433.252.972.652.062.373.793.703.383.682.971.241.591.611.67
Total Current Assets42.0851.7041.0949.0349.9748.6645.0744.4124.8920.1819.1612.9718.5129.5814.1322.4817.84
Property, Plant & Equipment2.042.262.582.051.441.421.120.590.420.440.460.530.560.510.070.02--
Goodwill----------------8.008.000.005.656.72--------
Intangible Assets0.200.231.561.831.792.282.522.763.263.503.604.9210.9013.860.02--0.26
Total Non-current Assets17.8118.4324.9024.5423.6423.9018.7517.0515.8015.2714.7120.3919.4620.712.221.510.91
Total Assets59.8970.1265.9873.5673.6172.5663.8261.4640.6935.4533.8733.3637.9750.2916.3523.9918.74
Accounts Payable18.1621.6519.5524.2915.6815.8715.0512.409.649.596.9010.8011.9411.6818.3816.7313.43
Total Current Liabilities46.6149.5956.6663.5360.9058.9551.6544.6832.5231.5227.0224.9425.8725.6119.8818.5515.44
Long-term Debt------15.90--------------------10.829.25--
Total Non-current Liabilities*5.325.505.959.6513.1119.5614.2315.4819.2514.1314.215.345.298.3211.149.590.36
Total Liabilities51.9355.0962.6273.1874.0178.5165.8860.1651.7845.6541.2330.2831.1633.9431.0128.1415.81
Retained Earnings(246.11)(238.25)(247.79)(238.50)(235.64)(235.37)(229.46)(221.81)(209.76)(202.86)(195.35)(177.85)(169.79)(156.00)(122.94)(108.58)(91.75)
Total Stockholder Equity7.9715.041.31(1.78)(2.33)(7.72)(4.21)(0.85)(12.67)(16.02)(12.01)(0.57)3.5113.18(17.56)(7.03)(0.07)

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Total Revenue47.2850.165.9760.1762.2265.7064.2553.3950.6644.1444.8638.6135.9533.1328.1231.4130.4629.0427.4224.95
Cost of Revenue5.285.934.237.417.438.649.435.015.024.605.364.784.554.214.074.724.645.255.445.10
Gross Profit42.0044.241.7352.7654.7957.0554.8248.3845.6439.5439.5033.8331.4028.9124.0526.7025.8223.7921.9819.85
Selling, General & Admin13.6515.186.7316.5917.5717.0619.9118.9318.5215.3115.5713.4012.1210.608.9312.4813.2512.3011.5910.70
Total Operating Expenses49.1353.179.0754.7355.6954.5153.8153.0751.9445.7241.6838.4036.2931.7631.9433.5141.4636.9035.6532.44
Operating Income(7.13)(8.93)(7.34)(1.97)(0.91)2.541.02(4.69)(6.31)(6.17)(2.17)(4.57)(4.90)(2.85)(7.88)(6.82)(15.64)(13.11)(13.66)(12.59)
Interest Expense(0.05)(0.06)(0.19)0.260.660.630.610.560.530.480.620.711.000.260.840.130.130.170.15--
Pretax Income(7.08)(8.87)(6.03)(3.39)----0.40(5.24)--------------------(18.00)(14.42)
Tax Provision----(0.12)0.17----0.170.23------------------------
Net Income(7.08)(8.87)18.85(3.81)(2.07)1.38(0.11)(5.13)(6.88)(6.77)(3.73)(6.12)(6.73)(4.01)(11.94)(7.28)(13.02)(13.30)(18.11)(14.35)
Basic EPS(0.16)(0.20)(0.14)(0.05)--------------------------------
Diluted EPS(0.16)(0.20)(0.14)(0.05)--------------------------------

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(6.93)0.44(3.28)(0.15)8.643.071.576.204.545.205.711.084.64(2.61)(1.97)(2.78)(10.10)(8.09)(5.83)(7.42)
Capital Expenditures0.070.110.160.800.800.120.230.450.640.180.110.030.030.03(0.01)0.020.090.270.180.05
Free Cash Flow*(6.99)0.34(3.44)(0.94)7.842.951.345.763.905.035.601.054.61(2.65)(1.96)(2.80)(10.19)(8.36)(6.00)(7.47)
Investing Cash Flow(1.63)(2.06)17.07(3.59)(3.70)(2.87)(2.72)(3.49)(3.13)(2.19)(2.22)(2.40)(2.30)(1.81)(1.77)(2.24)(2.51)(7.38)(1.58)(0.85)
Financing Cash Flow(0.78)(0.70)(0.79)(8.70)(3.10)(0.81)(1.43)(0.83)(0.82)(1.05)14.364.71(1.96)11.991.86(0.86)(0.75)(0.77)39.290.31

* Derived from reported values